Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries

被引:0
|
作者
Joost Swart
Gabriella Giancane
Gerd Horneff
Bo Magnusson
Michael Hofer
Еkaterina Alexeeva
Violeta Panaviene
Brigitte Bader-Meunier
Jordi Anton
Susan Nielsen
Fabrizio De Benedetti
Sylvia Kamphuis
Valda Staņēviča
Maria Tracahana
Laura Marinela Ailioaie
Elena Tsitsami
Ariane Klein
Kirsten Minden
Ivan Foeldvari
Johannes Peter Haas
Jens Klotsche
Anna Carin Horne
Alessandro Consolaro
Francesca Bovis
Francesca Bagnasco
Angela Pistorio
Alberto Martini
Nico Wulffraat
Nicolino Ruperto
机构
[1] Wilhelmina Children’s Hospital,Department of Pediatric Immunology and Rheumatology
[2] IRCCS Istituto Giannina Gaslini,Department of Pediatric and Adolescents medicine, Medical faculty
[3] Clinica Pediatrica e Reumatologia,Unité Romande d’Immuno
[4] PRINTO,Rhumatologie Pediatrique/Centre Hospitalier Universitaire Vaudois (CHUV), Pediatrie
[5] Asklepios Clinic Sankt Augustin,Vilnius University, Clinic of Children’s Diseases, Vilnius, Lithuania and Children’s Hospital
[6] University Hospital of Cologne,Division of Rheumatology
[7] Karolinska University Hospital,Sophia Children’s Hospital, Department of Paediatric Rheumatology
[8] Pediatric Rheumatology Unit,Department of Rheumatology
[9] University of Lausanne,Riga Stradins University, Department of Pediatrics
[10] University Hospital of Geneva,Hippokration General Hospital, First Department of pediatrics
[11] Federal State Autonomous Institution “National Medical Research Center of Children’s Health” of the Ministry of Health of the Russian Federation,Aghia Sophia Childrens Hospital, First Department of Pediatrics
[12] Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation,Dipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Mate
[13] Affiliate of Vilnius University Hospital Santariskiu Klinikos,Infantili (DiNOGMI)
[14] Université Paris-Descartes,undefined
[15] Institut IMAGINE,undefined
[16] Centre de référence national pour les Rhumatismes inflammatoires et les maladies Auto-Immunes Systémiques rares de l’Enfant (RAISE),undefined
[17] Unité d’Immunologie,undefined
[18] Hématologie et Rhumatologie Pediatrique,undefined
[19] Hôpital Necker-Enfants Malades,undefined
[20] Assistance Publique Hôpitaux de Paris,undefined
[21] Hospital Sant Joan de Déu,undefined
[22] Universitat de Barcelona,undefined
[23] Unidad de Reumatología Pediátrica,undefined
[24] Esplugues de Llobregat,undefined
[25] Juliane Marie Centret,undefined
[26] Rigshospitalet,undefined
[27] Paediatric Rheumatology Unit,undefined
[28] IRCCS Ospedale Pediatrico Bambino Gesù,undefined
[29] Erasmus University Medical Centre,undefined
[30] Erasmus University Medical Centre,undefined
[31] Children University Hospital,undefined
[32] Thessaloniki University School of Medicine,undefined
[33] Alexandru Ioan Cuza University of Iasi,undefined
[34] University of Athens Medical School,undefined
[35] German Rheumatism Research Centre,undefined
[36] Charité University Medicine,undefined
[37] Hamburg Centre for Pediatric and Adolescent Rheumatology,undefined
[38] German Center for Pediatric and Adolescent Rheumatology,undefined
[39] Deutsches Zentrum für Kinder- und Jugendrheumatologie,undefined
[40] Zentrum für Schmerztherapie junger Menschen,undefined
[41] IRCCS Istituto Giannina Gaslini,undefined
[42] Clinica Pediatrica e Reumatologia,undefined
[43] Università degli Studi di Genova,undefined
[44] IRCCS Istituto Giannina Gaslini,undefined
[45] Servizio di Epidemiologia e Biostatistica,undefined
[46] IRCCS Istituto Giannina Gaslini,undefined
[47] Direzione Scientifica,undefined
来源
Arthritis Research & Therapy | / 20卷
关键词
Juvenile idiopathic arthritis; Registry; Safety; Adverse events; Methotrexate; Biologics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 13 条
  • [1] Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and national registries
    Swart, Joost
    Giancane, Gabriella
    Horneff, Gerd
    Magnusson, Bo
    Hofer, Michael
    Alexeeva, Ekaterina
    Panaviene, Violeta
    Bader-Meunier, Brigitte
    Anton, Jordi
    Nielsen, Susan
    De Benedetti, Fabrizio
    Kamphuis, Sylvia
    Stanevica, Valda
    Tracahana, Maria
    Ailioaie, Laura Marinela
    Tsitsami, Elena
    Klein, Ariane
    Minden, Kirsten
    Foeldvari, Ivan
    Haas, Johannes Peter
    Klotsche, Jens
    Horne, Anna Carin
    Consolaro, Alessandro
    Bovis, Francesca
    Bagnasco, Francesca
    Pistorio, Angela
    Martini, Alberto
    Wulffraat, Nico
    Ruperto, Nicolino
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [2] Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries
    Joost Swart
    Alessandro Consolaro
    Gerd Horneff
    Kimme L Hyrich
    Francesca Bovis
    Jose Melo-Gomes
    Ekaterina Alexeeva
    Stefano Lanni
    Gerd Ganser
    Violeta Panaviene
    Jordi Anton
    Ivan Foeldvari
    Valda Stanevicha
    Susan Nielsen
    Ralf Trauzeddel
    Constantin Ailioaie
    Pierre Quartier
    Toni Hospach
    Gordana Susic
    Maria Trachana
    Frank Weller-Heinemann
    Alberto Martini
    Nico Wulffraat
    Nicolino Ruperto
    Pediatric Rheumatology, 12 (Suppl 1)
  • [3] Experiences with tumour necrosis factor-α inhibitors in patients with juvenile idiopathic arthritis: Hungarian data from the National Institute of Rheumatology and Physiotherapy Registry
    Sevcic, Krisztina
    Orban, Ilonka
    Brodszky, Valentin
    Bazso, Anna
    Balogh, Zsolt
    Poor, Gyula
    Kiss, Emese
    RHEUMATOLOGY, 2011, 50 (07) : 1337 - 1340
  • [4] Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry
    Manfredi, Andreina
    Fornaro, Marco
    Bazzani, Chiara
    Perniola, Simone
    Cauli, Alberto
    Rai, Alessandra
    Favalli, Ennio Giulio
    Bugatti, Serena
    Rossini, Maurizio
    Foti, Rosario
    Conti, Fabrizio
    Lopalco, Giuseppe
    Scalvini, Anna
    Garufi, Cristina
    Congia, Mattia
    Gorla, Roberto
    Gremese, Elisa
    Atzeni, Fabiola
    Caporali, Roberto
    Iannone, Florenzo
    Sebastiani, Marco
    FRONTIERS IN MEDICINE, 2024, 11
  • [5] Nearly 20% of children are not correctly classified according to current ilar classification in a PRINTO dataset of more than 12,000 juvenile idiopathic arthritis patients
    Consolaro A.
    Bovis F.
    Alexeeva E.
    Panaviene V.
    Anton J.
    Nielsen S.
    Susic G.
    Trachana M.
    Herlin T.
    Wulffraat N.
    Dolezalova P.
    Uziel Y.
    Shafaie N.
    Rumba-Rozenfelde I.
    Stanevicha V.
    Ruperto N.
    Lovell D.
    Ravelli A.
    Martini A.
    PRINTO
    Pediatric Rheumatology, 12 (Suppl 1) : 1 - 2
  • [6] Clusters of inflammation in COVID-19: descriptive analysis and prognosis on more than 15,000 patients from the Spanish SEMI-COVID-19 Registry
    Rubio-Rivas, Manuel
    Maria Mora-Lujan, Jose
    Formiga, Francesc
    Corrales Gonzalez, Miguel Angel
    Garcia Andreu, Maria del Mar
    Moreno-Torres, Victor
    Garcia Garcia, Gema Maria
    Alcala Pedrajas, Jose N.
    Boixeda, Ramon
    Perez-Lluna, Leticia
    Cortes-Rodriguez, Begona
    Mella-Perez, Carmen
    Navas Alcantara, Maria de la Sierra
    Lopez Reboiro, Manuel Lorenzo
    Alfaro-Lara, Veronica
    Perez-Martin, Santiago
    Angel Martin-Oterino, Jose
    Gracia Gutierrez, Anyuli
    Martin-Urda Diez-Canseco, Anabel
    Comas Casanova, Pere
    Perez Garcia, Cristina
    Varona, Jose F.
    Gomez-Huelgas, Ricardo
    Anton-Santos, Juan-Miguel
    Lumbreras-Bermejo, Carlos
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (04) : 1115 - 1127
  • [7] Risk of major adverse cardiovascular events in patients with rheumatoid arthritis treated with conventional synthetic, biologic and targeted synthetic disease-modifying antirheumatic drugs: observational data from the German RABBIT register
    Meissner, Yvette
    Schaefer, Martin
    Albrecht, Katinka
    Kekow, Joern
    Zinke, Silke
    Tony, Hans-Peter
    Strangfeld, Anja
    RMD OPEN, 2023, 9 (04):
  • [8] RETENTION RATE OF BIOLOGIC AND TARGETED SYNTHETIC ANTI-RHEUMATIC DRUGS IN ELDERLY PATIENTS AFFECTED BY RHEUMATOID ARTHRITIS: DATA FROM ITALIAN GISEA REGISTRY
    Manfredi, A.
    Iannone, F.
    Bugatti, S.
    Favalli, E. G.
    Franceschini, F.
    Atzeni, F.
    Bazzani, C.
    Cantatore, F. P.
    Caporali, R.
    Cauli, A.
    Conti, F.
    Ferraccioli, G.
    Foti, R.
    Fusaro, E.
    Iagnocco, A.
    Govoni, M.
    Gremese, E.
    Lapadula, G.
    Rai, A.
    Rossini, M.
    Semeraro, A.
    Sebastiani, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 860 - 860
  • [9] Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational study
    Ozen, Gulsen
    Pedro, Sofia
    Schumacher, Rebecca
    Simon, Teresa A.
    Michaud, Kaleb
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [10] Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational study
    Gulsen Ozen
    Sofia Pedro
    Rebecca Schumacher
    Teresa A. Simon
    Kaleb Michaud
    Arthritis Research & Therapy, 21